Caroline A Lamb

8PUBLICATIONS
31CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 04, 2026
Nuclear FGF2, androgen receptor and Wnt pathway activation define a targetable subset of antiprogestin-resistant luminal breast cancer.

Virginia Figueroa, Marcela I Coianis, Ana Sahores

|Dec 28, 2024
FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.

María S Rodriguez, Yamil D Mahmoud, Silvia Vanzulli

|Oct 21, 2022
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.

Andrés Elía, Leo Saldain, Silvia I Vanzulli

|Jan 03, 2022
New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer.

Cecilia Pérez Piñero, Sebastián Giulianelli, Caroline A Lamb

|Dec 03, 2020
Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.

Gonzalo R Sequeira, Ana Sahores, Tomás Dalotto-Moreno

|Sep 02, 2020
Hormone-Independent Mouse Mammary Adenocarcinomas with Different Metastatic Potential Exhibit Different Metabolic Signatures.

Daniela Bispo, Victoria Fabris, Caroline A Lamb

Pageof 2

Frequent Collaborators

4 joint publications

Claudia Lanari

2 joint publications

Cecilia Pérez Piñero

2 joint publications

Sebastián Giulianelli

2 joint publications

Andrés Elía